Proton therapy for vestibular schwannomas

Area of Science:

• Radiation Oncology
• Neurosurgery
• Medical Physics

Background:

• Vestibular schwannoma treatment involves radiation techniques.
• Proton beam therapy (PBT) offers potential advantages in dose distribution compared to photon therapy.
• PBT's Bragg peak minimizes dose to surrounding tissues, potentially reducing toxicity.

Purpose of the Study:

• To review the use of proton beam therapy (PBT) in treating vestibular schwannoma.
• To evaluate current evidence on PBT efficacy and toxicity for vestibular schwannoma.
• To discuss the potential benefits of advanced PBT techniques.

Main Methods:

• Review of published retrospective single-center series on PBT for vestibular schwannoma.
• Comparison of PBT outcomes with historical photon therapy data.
• Discussion of PBT uncertainties, including range uncertainty and safety margins.

Main Results:

• Limited data from retrospective studies do not indicate superior local control or cranial nerve toxicity compared to photon therapy.
• Integral dose reduction and potential decrease in normal tissue toxicity are theoretical benefits of PBT.
• Long-term toxicities like neurocognitive effects, stroke risk, and secondary malignancies remain unevaluated.

Conclusions:

• Current evidence does not definitively support improved outcomes with PBT for vestibular schwannoma over photon therapy.
• Outdated treatment planning and delivery methods in existing studies limit conclusions.
• Further research is needed to assess the efficacy of modern PBT, particularly Pencil Beam Scanning, and its benefits for specific patient subgroups.